SciELO - Scientific Electronic Library Online

vol.41 issue4Structural and functional neuroimaging studies in generalized anxiety disorder: a systematic reviewTourette’s disorder and sexual offenses: psychiatric-forensic considerations author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Brazilian Journal of Psychiatry

Print version ISSN 1516-4446On-line version ISSN 1809-452X

Braz. J. Psychiatry vol.41 no.4 São Paulo July/Aug. 2019  Epub July 29, 2019 

Letters to the Editor

Sociodemographic, psychiatric, and personality correlates of non-prescribed use of amphetamine medications for academic performance among medical students

Gelline M. Haas1 

Ana Clara Momo2 

Thaís M. Dias3 

Tosin A. Ayodele2 

Marcelo L. Schwarzbold4

1Programa de Residência Médica em Psiquiatria, Instituto de Psiquiatria de Santa Catarina, São José, SC, Brazil

2Curso de Medicina, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC, Brazil

3Curso de Medicina, Universidade do Sul de Santa Catarina (UNISUL), Palhoça, SC, Brazil

4Programa de Pós-Graduação em Ciências Médicas, UFSC, Florianópolis, SC, Brazil.

Use of psychostimulants without a medical indication to supposedly improve academic performance is common among medical students, but its correlates remain poorly understood.1,2 In this cross-sectional study (Plataforma Brasil ethical approval 52982815.9.0000.5636), we explored sociodemographic, psychiatric, and personality factors associated with this phenomenon. Students from all semesters of two universities (A, public, and B, private) in the metropolitan area of Florianópolis (state of Santa Catarina, Brazil) were invited, at the start or the end of classes, to answer an anonymous, self-report questionnaire about methylphenidate or lisdexamfetamine use patterns, gender, living situation, household monthly income per capita, and last-month cannabis use, as well as complete the Alcohol Use Disorders Identification Test - Consumption (AUDIT-C), 4-item Patient Health Questionnaire (PHQ-4), Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Self-Report Scale (ASRS), and Big Five Inventory (BFI) instruments.

Of 707 students enrolled, 698 (98.7%) completed the questions about methylphenidate or lisdexamfetamine use. Of these, 81.8% had never used these medications, 7.0% had ever used them with a medical prescription, and 11.2% had ever used them without a prescription. Students with prescribed use were excluded due to likely ADHD. Of those with non-prescribed use, 28.2% (n=22) used in the past month (median [interquartile interval], 2.0 [1.0-6.3] days of use in this period) and 71.8% (n=56) had done so more than 1 month before (2.0 [0.0-4.0] days of use in the past year). Motivations for non-prescribed use (more than one could be endorsed) were to study longer (84.6%), increase concentration (46.2%), stay awake (28.2%), experiment (15.4%), and party (10.3%).

First, we performed preliminary analyses (Mann-Whitney or chi-square tests) comparing students with non-prescribed use for academic performance (to study longer, increase concentration, or stay awake; n=71, or 10.2% of the sample) to students without use (n=571). Non-prescribed use for academic performance was significantly associated (p < 0.05) with studying in University B, older age, last-month cannabis use, higher AUDIT-C and lower BFI conscientiousness scores, and screening positive in the ASRS (score of 24 or greater in part A or B). We then simultaneously entered these variables into a multiple logistic regression model to define independent significant associations (Table 1).

Table 1 Multiple logistic regression model for the outcome of non-prescribed use of methylphenidate or lisdexamfetamine to enhance academic performance among medical students 

Outcome: No, n=521; Yes, n=63; Total, n=584; Missing, n=58
Summary: Hosmer-Lemeshow p-value = 0.06; Nagelkerke’s R2 = 0.17; c = 0.76
Explanatory variables Regression coefficient AOR (95%CI) p-value
Age 0.09 1.09 (1.03-1.16) 0.003
University 1.31 3.70 (2.03-6.72) 0.00002
ASRS positive 0.30 1.35 (0.68-2.69) 0.39
AUDIT-C 0.18 1.20 (1.05-1.36) 0.006
Cannabis use in the past month 0.71 2.04 (1.05-3.97) 0.04
BFI conscientiousness -0.25 0.78 (0.49-1.23) 0.28
Constant = -5.04

95%CI = 95% confidence interval; AOR = adjusted odds ratio; ASRS = Adult ADHD Self-Report Scale; AUDIT-C = Alcohol Use Disorders Identification Test - Consumption; BFI = Big Five Inventory.

Assumptions: numerical variables met the logit linearity assumption in the Box-Tidwell test (p > 0.05); no numerical variables showed a tolerance < 0.1 or a variance inflation factor > 5; no cases had a Cook’s distance > 1; 15 cases had an absolute standardized residual > 3; an analysis excluding these cases improved model fit (Hosmer-Lemeshow p = 0.74; Nagelkerke’s R2 = 0.35; c = 0.88), but did not change significance patterns.

Although many studies have addressed non-prescribed use of psychostimulant medication among medical students, ours was novel in its broad exploration of factors independently associated with this phenomenon. For example, very few studies in university students took personality measures into account.3 Prevalence of non-prescribed use was similar or somewhat lower in our sample than in other studies,1,2 and most students reported sporadic use. The associations with cannabis and alcohol consumption are in line with previous research and consistent with the idea that psychostimulant misuse may reflect a general tendency for greater substance use.4 In addition, the association with the variable university is consistent with the notion that psychostimulant misuse patterns vary widely locally and regionally.2 Overall, these results suggest it is reasonable to devise strategies to address psychostimulant misuse that take local factors (institutional or cultural, for example) into consideration, and following the same broad lines of strategies targeting other substances.5


We thank Drs. Flávio Vicente, Rafael Barni, Patricia Biava, and Alexandre Paim Diaz for their contributions, as well as the students and faculty of both universities involved.


1. Emanuel RM, Frellsen SL, Kashima KJ, Sanguino SM, Sierles FS, Lazarus CJ. Cognitive enhancement drug use among future physicians: findings from a multi-institutional census of medical students. J Gen Intern Med. 2013;28:1028-34. [ Links ]

2. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;100:96-106. [ Links ]

3. Benotsch EG, Jeffers AJ, Snipes DJ, Martin AM, Koester S. The five factor model of personality and the non-medical use of prescription drugs: associations in a young adult sample. Pers Individ Dif. 2013;55:852-5. [ Links ]

4. Arria AM, DuPont RL. Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do. J Addict Dis. 2010;29:417-26. [ Links ]

5. Rosenfield D, Hebert PC, Stanbrook MB, Flegel K, MacDonald NE. Time to address stimulant abuse on our campuses. CMAJ. 2011;183:1345. [ Links ]

Received: November 23, 2018; Accepted: April 17, 2019

Disclosure The authors report no conflicts of interest.

How to cite this article: Haas GM, Momo AC, Dias TM, Ayodele TA, Schwarzbold ML. Sociodemographic, psychiatric, and personality correlates of non-prescribed use of amphetamine medications for academic performance among medical students. Braz J Psychiatry. 2019;41:363-364.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.